A carregar...
Losartan and diabetic nephropathy: commentaries on the RENAAL study
The RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) study is a multinational, double-blind, randomized, placebo controlled trial which was recently published. It was aimed to evaluate the effect of the angiotensin receptor blocker losartan in patients with diabet...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | en |
| Publicado em: |
BioMed Central
2002
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC116616/ https://ncbi.nlm.nih.gov/pubmed/12119058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-1-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|